Dyskinesia clinical trials at UC Davis
1 research study open to eligible people
Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18-85
This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.
Detroit, Michigan and other locations